Annual Total Long Term Liabilities
$36.74 M
+$8.55 M+30.31%
31 December 2023
Summary:
Zevra Therapeutics annual total long term liabilities is currently $36.74 million, with the most recent change of +$8.55 million (+30.31%) on 31 December 2023. During the last 3 years, it has fallen by -$33.34 million (-47.57%). ZVRA annual total long term liabilities is now -62.68% below its all-time high of $98.46 million, reached on 01 December 2017.ZVRA Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Long Term Liabilities
$87.30 M
+$5.82 M+7.14%
30 September 2024
Summary:
Zevra Therapeutics quarterly total long term liabilities is currently $87.30 million, with the most recent change of +$5.82 million (+7.14%) on 30 September 2024. Over the past year, it has increased by +$37.50 million (+75.31%). ZVRA quarterly long term liabilities is now -25.75% below its all-time high of $117.58 million, reached on 01 March 2016.ZVRA Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ZVRA Long Term Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +30.3% | +75.3% |
| 3 y3 years | -47.6% | +4885.7% |
| 5 y5 years | -54.8% | +19.4% |
ZVRA Long Term Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -47.6% | +2206.5% | at high | +6817.6% |
| 5 y | 5 years | -54.8% | +2206.5% | at high | +6817.6% |
| alltime | all time | -62.7% | +2206.5% | -25.8% | +6817.6% |
Zevra Therapeutics Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $87.30 M(+7.1%) |
| June 2024 | - | $81.48 M(+12.3%) |
| Mar 2024 | - | $72.56 M(+97.5%) |
| Dec 2023 | $36.74 M(+30.3%) | $36.74 M(-26.2%) |
| Sept 2023 | - | $49.80 M(+165.3%) |
| June 2023 | - | $18.77 M(-4.1%) |
| Mar 2023 | - | $19.57 M(-30.6%) |
| Dec 2022 | $28.20 M(+1670.1%) | $28.20 M(+62.7%) |
| Sept 2022 | - | $17.33 M(-3.0%) |
| June 2022 | - | $17.87 M(+1315.7%) |
| Mar 2022 | - | $1.26 M(-20.8%) |
| Dec 2021 | $1.59 M(-97.7%) | - |
| Dec 2021 | - | $1.59 M(-9.0%) |
| Sept 2021 | - | $1.75 M(-19.5%) |
| June 2021 | - | $2.17 M(+11.8%) |
| Mar 2021 | - | $1.95 M(-97.2%) |
| Dec 2020 | $70.08 M(-11.9%) | $70.08 M(+2464.4%) |
| Sept 2020 | - | $2.73 M(+3.4%) |
| June 2020 | - | $2.64 M(+32.0%) |
| Mar 2020 | - | $2.00 M(-97.5%) |
| Dec 2019 | $79.53 M | $79.53 M(+8.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2019 | - | $73.10 M(-8.1%) |
| June 2019 | - | $79.58 M(+0.1%) |
| Mar 2019 | - | $79.53 M(-2.2%) |
| Dec 2018 | $81.31 M(-17.4%) | $81.31 M(-15.1%) |
| Sept 2018 | - | $95.76 M(-4.2%) |
| June 2018 | - | $99.94 M(-7.9%) |
| Mar 2018 | - | $108.52 M(+10.2%) |
| Dec 2017 | $98.46 M(+1.6%) | $98.46 M(-2.3%) |
| Sept 2017 | - | $100.77 M(-0.9%) |
| June 2017 | - | $101.73 M(-2.9%) |
| Mar 2017 | - | $104.76 M(+8.1%) |
| Dec 2016 | $96.94 M(+72.0%) | $96.94 M(-1.7%) |
| Sept 2016 | - | $98.64 M(+1.8%) |
| June 2016 | - | $96.91 M(-17.6%) |
| Mar 2016 | - | $117.58 M(+108.6%) |
| Dec 2015 | $56.37 M(-3.3%) | $56.37 M(-6.6%) |
| Sept 2015 | - | $60.37 M(+3.8%) |
| June 2015 | - | $58.17 M(-9.7%) |
| Mar 2015 | - | $64.44 M(+10.6%) |
| Dec 2014 | $58.29 M(+171.7%) | $58.29 M |
| Dec 2013 | $21.45 M | - |
FAQ
- What is Zevra Therapeutics annual total long term liabilities?
- What is the all time high annual total long term liabilities for Zevra Therapeutics?
- What is Zevra Therapeutics annual total long term liabilities year-on-year change?
- What is Zevra Therapeutics quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Zevra Therapeutics?
- What is Zevra Therapeutics quarterly long term liabilities year-on-year change?
What is Zevra Therapeutics annual total long term liabilities?
The current annual total long term liabilities of ZVRA is $36.74 M
What is the all time high annual total long term liabilities for Zevra Therapeutics?
Zevra Therapeutics all-time high annual total long term liabilities is $98.46 M
What is Zevra Therapeutics annual total long term liabilities year-on-year change?
Over the past year, ZVRA annual total long term liabilities has changed by +$8.55 M (+30.31%)
What is Zevra Therapeutics quarterly total long term liabilities?
The current quarterly long term liabilities of ZVRA is $87.30 M
What is the all time high quarterly long term liabilities for Zevra Therapeutics?
Zevra Therapeutics all-time high quarterly total long term liabilities is $117.58 M
What is Zevra Therapeutics quarterly long term liabilities year-on-year change?
Over the past year, ZVRA quarterly total long term liabilities has changed by +$37.50 M (+75.31%)